Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,485,339
-
Shares change
-
+73,513
-
Total reported value, excl. options
-
$7,376,000
-
Value change
-
+$360,760
-
Number of buys
-
7
-
Number of sells
-
-4
-
Price
-
$4.97
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q2 2024
17 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q2 2024.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,485,339 shares
.
Largest 10 shareholders include PINNACLE ASSOCIATES LTD (564,360 shares), VILLERE ST DENIS J & CO LLC (389,867 shares), Roumell Asset Management, LLC (276,430 shares), BROWN ADVISORY INC (119,465 shares), AMH Equity Ltd (75,647 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (39,760 shares), BANK OF AMERICA CORP /DE/ (7,300 shares), UBS Group AG (7,142 shares), PNC Financial Services Group, Inc. (3,600 shares), and Redwood Wealth Management Group, LLC (1,310 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.